Detalles de la búsqueda
1.
[Efficacy and safety analysis of bupivacaine liposome for pericapsular nerve group block for postoperative analgesia in elderly patients with hip replacement].
Zhonghua Yi Xue Za Zhi
; 104(3): 180-185, 2024 Jan 16.
Artículo
en Zh
| MEDLINE | ID: mdl-38220442
2.
[Research progress on the mechanism of action of heme oxygenase-1 regulating ferroptosis in non-alcoholic fatty liver disease].
Zhonghua Gan Zang Bing Za Zhi
; 32(3): 262-267, 2024 Mar 20.
Artículo
en Zh
| MEDLINE | ID: mdl-38584112
3.
[Interpretation of the 2024 American Diabetes Association guidelines for the comprehensive management of non-alcoholic fatty liver disease combined with diabetes mellitus].
Zhonghua Gan Zang Bing Za Zhi
; 32(6): 504-507, 2024 Jun 20.
Artículo
en Zh
| MEDLINE | ID: mdl-38964892
4.
[Value of constructing a non-invasive diagnostic model based on serum heme oxygenase-1 and glucose regulatory protein 78 for non-alcoholic fatty liver disease].
Zhonghua Gan Zang Bing Za Zhi
; 32(3): 228-234, 2024 Mar 20.
Artículo
en Zh
| MEDLINE | ID: mdl-38584104
5.
[A study on the diagnostic value of GP73 in liver fibrosis among patients with chronic liver disease].
Zhonghua Nei Ke Za Zhi
; 62(1): 49-53, 2023 Jan 01.
Artículo
en Zh
| MEDLINE | ID: mdl-36631037
6.
[Association of sleep duration and risk of frailty among the elderly over 80 years old in China: a prospective cohort study].
Zhonghua Yu Fang Yi Xue Za Zhi
; 57(5): 607-613, 2023 May 06.
Artículo
en Zh
| MEDLINE | ID: mdl-37165807
7.
[Precise immunological classification guidance for early initiation of antiviral therapy in patients with chronic HBV infection].
Zhonghua Gan Zang Bing Za Zhi
; 31(3): 228-232, 2023 Mar 20.
Artículo
en Zh
| MEDLINE | ID: mdl-37137845
8.
[Emphasis on targeted and immunotherapy for liver injury in hepatocellular carcinoma].
Zhonghua Gan Zang Bing Za Zhi
; 31(11): 1121-1124, 2023 Nov 20.
Artículo
en Zh
| MEDLINE | ID: mdl-38238942
9.
[A clinical study of targeted immunotherapy combined with hepatic arterial chemoembolization in the treatment of liver injury associated with primary liver cancer].
Zhonghua Gan Zang Bing Za Zhi
; 31(11): 1156-1162, 2023 Nov 20.
Artículo
en Zh
| MEDLINE | ID: mdl-38238948
10.
[Strategies for liver injury caused by hepatocellular carcinoma targeted therapy].
Zhonghua Gan Zang Bing Za Zhi
; 31(11): 1129-1132, 2023 Nov 20.
Artículo
en Zh
| MEDLINE | ID: mdl-38238944
11.
[Clinical study of serum human-ßeta-defensin-1 level for evaluating short-term prognosis in patients with acute-on-chronic liver failure].
Zhonghua Gan Zang Bing Za Zhi
; 31(4): 415-421, 2023 Apr 20.
Artículo
en Zh
| MEDLINE | ID: mdl-37248981
12.
[Clinical value of plasma scaffold protein SEC16A in evaluating hepatitis B-related liver cirrhosis and hepatocellular carcinoma].
Zhonghua Gan Zang Bing Za Zhi
; 31(6): 621-626, 2023 Jun 20.
Artículo
en Zh
| MEDLINE | ID: mdl-37400387
13.
[Real-world study on the efficacy and safety of first-line antiviral therapy for chronic hepatitis B].
Zhonghua Gan Zang Bing Za Zhi
; 31(8): 855-861, 2023 Aug 20.
Artículo
en Zh
| MEDLINE | ID: mdl-37723068
14.
[Ten-year changes in clinical characteristics and antiviral treatment patterns of chronic hepatitis B in China: a CR-HepB-based real-world study].
Zhonghua Gan Zang Bing Za Zhi
; 31(7): 698-704, 2023 Jul 20.
Artículo
en Zh
| MEDLINE | ID: mdl-37580251
15.
[Study on HBV-related acute-on-chronic liver failure risk factors and novel predictive survival model].
Zhonghua Gan Zang Bing Za Zhi
; 31(1): 84-89, 2023 Jan 20.
Artículo
en Zh
| MEDLINE | ID: mdl-36948854
16.
[Recompensation of complications in patients with hepatitis B virus-related decompensated cirrhosis treated with entecavir antiviral therapy].
Zhonghua Gan Zang Bing Za Zhi
; 31(7): 692-697, 2023 Jul 20.
Artículo
en Zh
| MEDLINE | ID: mdl-37580250
17.
[Interpretation of the essential updates in guidelines for the prevention and treatment of chronic hepatitis B (Version 2022)].
Zhonghua Gan Zang Bing Za Zhi
; 31(4): 385-388, 2023 Apr 20.
Artículo
en Zh
| MEDLINE | ID: mdl-37248977
18.
[Long non-coding RNA LOC101927476 inhibits invasion, migration, and proliferation of ovarian cancer cell lines].
Zhonghua Zhong Liu Za Zhi
; 44(1): 104-111, 2022 Jan 23.
Artículo
en Zh
| MEDLINE | ID: mdl-35073656
19.
[Advances in targeted and immune therapies for hepatocellular carcinoma].
Zhonghua Gan Zang Bing Za Zhi
; 30(9): 905-911, 2022 Sep 20.
Artículo
en Zh
| MEDLINE | ID: mdl-36299181
20.
[Hepatocellular carcinoma immune microenvironment].
Zhonghua Gan Zang Bing Za Zhi
; 30(9): 923-930, 2022 Sep 20.
Artículo
en Zh
| MEDLINE | ID: mdl-36299184